H
Hyperfine Inc
NASDAQ:HYPR
Hyperfine Inc
NASDAQ:HYPR
Price:
0.79 USD
-0.89%
Market Closed
Updated:
May 11, 2024
Section:
Relative Value
The Relative Value of one HYPR stock under the Base Case scenario is 0.59 USD. Compared to the current market price of 0.79 USD, Hyperfine Inc is Overvalued by 26%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
HYPR
Relative Value
Base Case
0.59
USD
Overvaluation 26%
H
Valuation Multiples
Multiples Across Competitors
HYPR Competitors Multiples
Hyperfine Inc Competitors
Hyperfine Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
H
|
Hyperfine Inc
NASDAQ:HYPR
|
56.8m USD | 5.1 | -1.3 | 0.4 | 0.4 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
182.2B USD | 4.5 | 32.4 | 19.1 | 28.5 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
137.2B USD | 18.7 | 69 | 56.6 | 71 | |
| US |
|
Stryker Corp
NYSE:SYK
|
125.9B USD | 6 | 37.5 | 24.3 | 29.9 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
110.1B USD | 3.4 | 26.2 | 13.9 | 19.7 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
108.3B USD | 7.4 | 61.3 | 30.8 | 45.6 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
68.1B USD | 3.5 | 55.9 | 18.7 | 39.5 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
58.7B EUR | 2.7 | 38.6 | 18.5 | 31.3 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
52.2B USD | 8.5 | 36.9 | 26.8 | 29 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
368.5B CNY | 10.3 | 30.3 | 27.8 | 27.8 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
50.3B USD | 13.2 | 78.7 | 58.8 | 76.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
